CH624935A5 - - Google Patents

Download PDF

Info

Publication number
CH624935A5
CH624935A5 CH1022576A CH1022576A CH624935A5 CH 624935 A5 CH624935 A5 CH 624935A5 CH 1022576 A CH1022576 A CH 1022576A CH 1022576 A CH1022576 A CH 1022576A CH 624935 A5 CH624935 A5 CH 624935A5
Authority
CH
Switzerland
Prior art keywords
formula
compound
radical
compounds
acetamide
Prior art date
Application number
CH1022576A
Other languages
German (de)
English (en)
Inventor
Giorgio Pifferi
Mario Pinza
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of CH624935A5 publication Critical patent/CH624935A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
CH1022576A 1975-08-13 1976-08-11 CH624935A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT26326/75A IT1045043B (it) 1975-08-13 1975-08-13 Derivati pirrolidinici

Publications (1)

Publication Number Publication Date
CH624935A5 true CH624935A5 (ja) 1981-08-31

Family

ID=11219233

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1022576A CH624935A5 (ja) 1975-08-13 1976-08-11

Country Status (27)

Country Link
US (1) US4118396A (ja)
JP (1) JPS5822034B2 (ja)
AR (1) AR212176A1 (ja)
AT (1) AT353783B (ja)
AU (1) AU506651B2 (ja)
BE (1) BE845099A (ja)
CA (1) CA1077947A (ja)
CH (1) CH624935A5 (ja)
CS (1) CS214766B2 (ja)
DD (1) DD127966B3 (ja)
DE (1) DE2635853C2 (ja)
DK (1) DK156055C (ja)
ES (1) ES450643A1 (ja)
FI (1) FI62290C (ja)
FR (1) FR2320741A1 (ja)
GB (1) GB1550160A (ja)
HU (1) HU173742B (ja)
IN (1) IN144871B (ja)
IT (1) IT1045043B (ja)
MX (1) MX4717E (ja)
NL (1) NL179052C (ja)
NO (1) NO146909C (ja)
NZ (1) NZ181726A (ja)
PL (1) PL101471B1 (ja)
SE (1) SE420599B (ja)
SU (1) SU663302A3 (ja)
YU (1) YU40147B (ja)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075564B (it) * 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
IT1075280B (it) 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
GB1580559A (en) * 1977-11-24 1980-12-03 Wyeth John & Brother Ltd Amide cerivatives
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
NL8004025A (nl) * 1979-08-09 1981-02-11 Hoffmann La Roche Pyrrolidinederivaten en werkwijze voor het bereiden daarvan alsmede geneesmiddel.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
IT1206699B (it) * 1984-02-27 1989-04-27 Isf Spa Procedimento per preparare derivati di pirrolidone.
CH666483A5 (de) * 1985-01-16 1988-07-29 Lonza Ag Verfahren zur herstellung von thiotetronsaeure.
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0223328B1 (en) 1985-07-26 1992-01-29 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing oxiracetam
HU195773B (en) * 1985-09-24 1988-07-28 Lonza Ag Process for preparing alkyl esters of 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid
IL80071A0 (en) * 1985-09-24 1986-12-31 Lonza Ag Pyrrolidine acetamide derivatives
CH668423A5 (de) * 1986-06-19 1988-12-30 Lonza Ag Verfahren zur herstellung von 4-alkoxy-3-pyrrolin-2-onen.
US4677114A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Pyrrolidone-2 derivatives and pharmaceutical compositions thereof
CH668424A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on-l-yl-acetamid, dessen herstellung und verwendung.
CH668422A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa
CH667655A5 (de) * 1986-09-24 1988-10-31 Lonza Ag Verfahren zur herstellung von 4-alkoxy-2(5h)-thiophenonen.
CH670644A5 (ja) * 1986-12-18 1989-06-30 Lonza Ag
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
DE3813416A1 (de) * 1988-04-21 1989-11-02 Hoechst Ag 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
JP2660201B2 (ja) * 1988-08-05 1997-10-08 塩野義製薬株式会社 新規ピロロ[1,4]ベンゾジアゼピン誘導体および老人性痴呆薬
DE58909320D1 (de) * 1988-09-06 1995-08-03 Lonza Ag Verfahren zur Herstellung von 5-Alkyltetramsäuren.
IL93051A0 (en) * 1989-01-17 1990-11-05 Hoffmann La Roche ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides,their preparation and pharmaceutical compositions containing them
FI95034C (fi) * 1989-03-15 1995-12-11 Lonza Ag Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi
CH680293A5 (ja) * 1990-06-26 1992-07-31 Lonza Ag
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
US7608636B2 (en) 2000-12-28 2009-10-27 Hamilton Pharmaceuticals, Inc. Medicines for treatment and prevention of neurogenic pain
WO2007065634A1 (en) * 2005-12-07 2007-06-14 Ucb Pharma, S.A. 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
CN102227217A (zh) 2008-10-16 2011-10-26 约翰斯.霍普金斯大学 改善认知功能的方法和组合物
EP2533645B1 (en) * 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
DK2968220T3 (da) 2013-03-15 2021-06-14 Agenebio Inc Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
BR112017025031B1 (pt) 2015-05-22 2023-03-21 Agenebio, Inc Composições farmacêuticas de liberação prolongada de levetiracetam
CN105820102A (zh) * 2016-05-10 2016-08-03 武汉工程大学 奥拉西坦的合成工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011886B (de) * 1952-04-29 1957-07-11 Waldemar Kutscher Dr Ing Dr Me Verfahren zur Herstellung von Aminoalkylpyrrolen
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
US3541111A (en) * 1968-05-08 1970-11-17 Du Pont Pyrrolinecarboxanilide compounds
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines

Also Published As

Publication number Publication date
BE845099A (fr) 1977-02-11
FI762314A (ja) 1977-02-14
DK156055B (da) 1989-06-19
FR2320741A1 (fr) 1977-03-11
AT353783B (de) 1979-12-10
AU1679776A (en) 1978-02-16
DD127966A5 (de) 1977-10-26
CS214766B2 (en) 1982-05-28
DK365176A (da) 1977-02-14
DD127966B3 (de) 1983-03-30
CA1077947A (en) 1980-05-20
NZ181726A (en) 1978-09-20
ATA589476A (de) 1979-05-15
DE2635853C2 (de) 1984-05-30
US4118396A (en) 1978-10-03
SE7608938L (sv) 1977-02-14
YU196476A (en) 1982-06-30
FR2320741B1 (ja) 1979-03-02
JPS5223072A (en) 1977-02-21
ES450643A1 (es) 1977-08-01
AR212176A1 (es) 1978-05-31
PL101471B1 (pl) 1978-12-30
HU173742B (hu) 1979-08-28
YU40147B (en) 1985-08-31
NL179052B (nl) 1986-02-03
FI62290C (fi) 1982-12-10
NO146909B (no) 1982-09-20
GB1550160A (en) 1979-08-08
JPS5822034B2 (ja) 1983-05-06
AU506651B2 (en) 1980-01-17
NL179052C (nl) 1986-07-01
DE2635853A1 (de) 1977-02-24
IT1045043B (it) 1980-04-21
SE420599B (sv) 1981-10-19
MX4717E (es) 1982-08-13
IN144871B (ja) 1978-07-22
DK156055C (da) 1989-12-04
FI62290B (fi) 1982-08-31
NO146909C (no) 1982-12-29
NL7608946A (nl) 1977-02-15
NO762791L (ja) 1977-02-15
SU663302A3 (ru) 1979-05-15

Similar Documents

Publication Publication Date Title
CH624935A5 (ja)
DE69231854T2 (de) Substituierte (s)-3-phenylpiperidin derivate, deren herstellung und deren verwendung als dopamin autorezeptor antagonisten
DE69107250T2 (de) Neue 4-Aminobuttersäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneizubereitungen.
DE2847622A1 (de) Neue chinazolin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE1117584B (de) Verfahren zur Herstellung von Phentiazinderivaten
DE2002840B2 (de) Neue 23,5-trisubstit-2'-Hydroxy-6,7-benzomorphane
DE2807623C2 (de) 2-Phenoxyphenyl-pyrrolidinderivate, deren Salze, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2362754C2 (de) Cyclopropylalkylaminoreste enthaltende Oxazolinverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
CH626615A5 (ja)
DE2044172A1 (de) Neue Pyrroldenvate, ein Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittelzubereitungen
DE2705416A1 (de) Neue derivate des m-trifluormethylphenylpiperidins und deren salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE1071087B (ja)
DE68905363T2 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DE2817494A1 (de) Aminoalkohol-derivat
DE1075620B (de) Verfahren zur Herstellung von Phenthiazmderivaten
DE2635854A1 (de) Pyrrolin-2-on-derivate, verfahren zu ihrer herstellung und sie enthaltendes arzneimittel
DE1059460B (de) Verfahren zur Herstellung von Phenthiazinderivaten
DE2745280A1 (de) Tricyclische verbindungen
DE1154806B (de) Verfahren zur Herstellung von Phenthiazinderivaten
EP0089926A2 (de) Pharmazeutische Präparate enthaltend stickstoffhaltige Tetracyclen sowie neue Verbindungen dieser Art
AT215997B (de) Verfahren zur Herstellung neuer Ester der α-Phenyl-α-piperidyl-(2)-essigsäure
DE2404924A1 (de) Ergolinderivate
AT218521B (de) Verfahren zur Herstellung von neuen Derivaten des Piperidins und Tetrahydropyridins
DE1670186C (de) p Alkoxy piperidin amide und Verfahren zu ihrer Herstellung
DE2055264C3 (de) Thienyl(2) -essigsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
PL Patent ceased